annual shareholders equity:
$360.18M-$2.32M(-0.64%)Summary
- As of today (May 29, 2025), NVCR annual stockholders equity is $360.18 million, with the most recent change of -$2.32 million (-0.64%) on December 31, 2024.
- During the last 3 years, NVCR annual shareholders equity has fallen by -$50.31 million (-12.26%).
- NVCR annual shareholders equity is now -24.42% below its all-time high of $476.53 million, reached on December 31, 2020.
Performance
NVCR Shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly shareholders equity:
$361.96M+$1.78M(+0.49%)Summary
- As of today (May 29, 2025), NVCR quarterly stockholders equity is $361.96 million, with the most recent change of +$1.78 million (+0.49%) on March 31, 2025.
- Over the past year, NVCR quarterly shareholders equity has increased by +$2.60 million (+0.72%).
- NVCR quarterly shareholders equity is now -24.04% below its all-time high of $476.53 million, reached on December 31, 2020.
Performance
NVCR quarterly shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Shareholders equity Formula
Shareholders Equity = Total Assets − Total Liabilities
NVCR Shareholders equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -0.6% | +0.7% |
| 3 y3 years | -12.3% | -17.0% |
| 5 y5 years | +65.4% | +49.6% |
NVCR Shareholders equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -18.4% | at low | -18.7% | +0.7% |
| 5 y | 5-year | -24.4% | +65.4% | -24.0% | +49.6% |
| alltime | all time | -24.4% | +268.0% | -24.0% | +269.8% |
NVCR Shareholders equity History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $361.96M(+0.5%) |
| Dec 2024 | $360.18M(-0.6%) | $360.18M(-0.2%) |
| Sep 2024 | - | $360.78M(-0.3%) |
| Jun 2024 | - | $361.75M(+0.7%) |
| Mar 2024 | - | $359.36M(-0.9%) |
| Dec 2023 | $362.50M(-17.8%) | $362.50M(-7.9%) |
| Sep 2023 | - | $393.70M(-5.3%) |
| Jun 2023 | - | $415.68M(-3.8%) |
| Mar 2023 | - | $432.15M(-2.0%) |
| Dec 2022 | $441.17M(+7.5%) | $441.17M(-0.9%) |
| Sep 2022 | - | $445.40M(+0.8%) |
| Jun 2022 | - | $441.67M(+1.3%) |
| Mar 2022 | - | $435.88M(+6.2%) |
| Dec 2021 | $410.49M(-13.9%) | $410.49M(-0.6%) |
| Sep 2021 | - | $413.16M(+4.0%) |
| Jun 2021 | - | $397.27M(+6.8%) |
| Mar 2021 | - | $372.13M(-21.9%) |
| Dec 2020 | $476.53M(+118.8%) | $476.53M(+55.2%) |
| Sep 2020 | - | $307.04M(+14.6%) |
| Jun 2020 | - | $267.82M(+10.7%) |
| Mar 2020 | - | $241.95M(+11.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | $217.79M(+94.0%) | $217.79M(+14.4%) |
| Sep 2019 | - | $190.37M(+19.8%) |
| Jun 2019 | - | $158.91M(+25.7%) |
| Mar 2019 | - | $126.39M(+12.6%) |
| Dec 2018 | $112.26M(-1.1%) | $112.26M(-2.3%) |
| Sep 2018 | - | $114.94M(+2.5%) |
| Jun 2018 | - | $112.08M(+5.6%) |
| Mar 2018 | - | $106.12M(-6.6%) |
| Dec 2017 | $113.56M(-20.2%) | $113.56M(-2.7%) |
| Sep 2017 | - | $116.69M(-0.7%) |
| Jun 2017 | - | $117.55M(-8.8%) |
| Mar 2017 | - | $128.90M(-9.4%) |
| Dec 2016 | $142.34M(-43.2%) | $142.34M(-10.0%) |
| Sep 2016 | - | $158.24M(-15.2%) |
| Jun 2016 | - | $186.65M(-15.3%) |
| Mar 2016 | - | $220.43M(-12.1%) |
| Dec 2015 | $250.82M(+156.3%) | $250.82M(+106.9%) |
| Sep 2015 | - | $121.22M(-16.0%) |
| Jun 2015 | - | $144.31M(+47.4%) |
| Dec 2014 | $97.88M(-43.0%) | $97.88M |
| Dec 2013 | $171.78M | - |
FAQ
- What is NovoCure Limited annual stockholders equity?
- What is the all time high annual shareholders equity for NovoCure Limited?
- What is NovoCure Limited annual shareholders equity year-on-year change?
- What is NovoCure Limited quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for NovoCure Limited?
- What is NovoCure Limited quarterly shareholders equity year-on-year change?
What is NovoCure Limited annual stockholders equity?
The current annual shareholders equity of NVCR is $360.18M
What is the all time high annual shareholders equity for NovoCure Limited?
NovoCure Limited all-time high annual stockholders equity is $476.53M
What is NovoCure Limited annual shareholders equity year-on-year change?
Over the past year, NVCR annual stockholders equity has changed by -$2.32M (-0.64%)
What is NovoCure Limited quarterly stockholders equity?
The current quarterly shareholders equity of NVCR is $361.96M
What is the all time high quarterly shareholders equity for NovoCure Limited?
NovoCure Limited all-time high quarterly stockholders equity is $476.53M
What is NovoCure Limited quarterly shareholders equity year-on-year change?
Over the past year, NVCR quarterly stockholders equity has changed by +$2.60M (+0.72%)